Peptide Regulatory Tracker
Status, timeline and sources for each peptide: FDA-approved, under review, compounding status, or not approved.
| Peptide | FDA-approved drug? | 503A Bulks List | Latest action |
|---|---|---|---|
| BPC-157 | No | Not listed | Advisory committee voted 8–6 (1 abstention) to recommend, Jul 23, 2026; FDA staff opposed. Details |
| KPV, TB-500, MOTS-c, Semax, Epitalon | No | Not listed | Recommended by advisory committee, Jul 23–24, 2026 (non-binding) |
| Emideltide (DSIP) | No | Not listed | Not recommended by advisory committee, Jul 24, 2026 |
Sources: AJMC, FDA. Interim policy pending: what we know. Status as of Oct 20, 2026.
New evidence reviews in this section are being researched and fact-checked. Check back soon.